LMAT - LeMaitre Vascular - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LMAT is currently covered by 5 analysts with an average price target of $88.88. This is a potential upside of $7.64 (9.4%) from yesterday's end of day stock price of $81.24.

LeMaitre Vascular's activity chart (see below) currently has 84 price targets and 75 ratings on display. The stock rating distribution of LMAT is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 98.42% with an average time for these price targets to be met of 269.45 days.

Highest price target for LMAT is $110, Lowest price target is $100, average price target is $94.25.

Most recent stock forecast was given by MICHAEL PETUSKY from BARRINGTON on 22-Jul-2025. First documented stock forecast 24-Jun-2014.

Currently out of the existing stock ratings of LMAT, 12 are a BUY (75%), 4 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

11 days ago
(22-Jul-2025)

17/17 (100%)

$-1.73 (-1.83%)

151

Buy

$110

$28.76 (35.40%)

$75

5 months 5 days ago
(28-Feb-2025)

11/12 (91.67%)

$10.09 (10.10%)

265

Buy

$100

$18.76 (23.09%)

$75

9 months 1 days ago
(01-Nov-2024)

10/11 (90.91%)

$5.27 (5.56%)

156

Buy

$100

$18.76 (23.09%)

$13

1 years 2 months 2 days ago
(31-May-2024)

2/2 (100%)

$21.4 (27.23%)

105

Hold

$67

$-14.24 (-17.53%)

$70

1 years 11 months 30 days ago
(03-Aug-2023)

2/2 (100%)

$10.53 (18.65%)

552

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LMAT (LeMaitre Vascular) average time for price targets to be met?

On average it took 269.45 days on average for the stock forecasts to be realized with a an average price target met ratio 98.42

Which analyst has the current highest performing score on LMAT (LeMaitre Vascular) with a proven track record?

ANTHONY PETRONE

Which analyst has the most public recommendations on LMAT (LeMaitre Vascular)?

Anthony Petrone works at MIZUHO and has 8 price targets and 5 ratings on LMAT

Which analyst is the currently most bullish on LMAT (LeMaitre Vascular)?

Brooks O'neil with highest potential upside - $28.76

Which analyst is the currently most reserved on LMAT (LeMaitre Vascular)?

Chris Lewis with lowest potential downside - -$55.24

LeMaitre Vascular in the News

At US$81.24, Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth Looking At Closely?

LeMaitre Vascular, Inc. (NASDAQ:LMAT), might not be a large cap stock, but it saw significant share price movement during recent months on the NASDAQGM, rising to highs of US$92.60 and falling to the lows of US$78.70. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at...

Why LeMaitre (LMAT) Shares Are Sliding Today

What Happened? Shares of medical device company LeMaitre Vascular (NASDAQ:LMAT) fell 12.2% in the afternoon session after the company reported weak first quarter 2025 results with a significant miss on full-year EPS guidance and underwhelming EPS guidance for next quarter. On the other hand, LeMaitre’s full-year revenue guidance topped analysts’ expectations and organic revenue outperform...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?